Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
-3.68%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$44.3B
AUM Growth
-$9.29B
(-17%)
Cap. Flow
-$5.52B
Cap. Flow
% of AUM
-12.46%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| 1 |
S&P Global
SPGI
|
$160M |
| 2 |
Clorox
CLX
|
$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
$134M |
| 4 |
Pfizer
PFE
|
$108M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$101M |
Top Sells
| 1 |
TSMC
TSM
|
$903M |
| 2 |
Chevron
CVX
|
$268M |
| 3 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$257M |
| 4 |
Exxon Mobil
XOM
|
$238M |
| 5 |
AbbVie
ABBV
|
$205M |
Sector Composition
| 1 | Healthcare | 22.63% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 8.91% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
HighPeak Energy
HPK
$945M
| $4K | ﹤0.01% |
+165
| New | +$4K |
|
1977
MidWestOne Financial Group
MOFG
$618M
| $4K | ﹤0.01% |
107
+104
| +3,467% | +$3.89K |
|
1978
Neurogene
NGNE
$285M
| $4K | ﹤0.01% |
118
-1,169
| -91% | -$39.6K |
|
1979
Quanex
NX
$836M
| $4K | ﹤0.01% |
196
-211
| -52% | -$4.31K |
|
1980
Republic Bancorp
RBCAA
$1.5B
| $4K | ﹤0.01% |
89
-49
| -36% | -$2.2K |
|
1981
Banco Santander
SAN
$141B
| $4K | ﹤0.01% |
1,164
-604
| -34% | -$2.08K |
|
1982
Stellantis
STLA
$26.2B
| $4K | ﹤0.01% |
275
| – | – |
|
1983
Sterling Infrastructure
STRL
$8.7B
| $4K | ﹤0.01% |
+155
| New | +$4K |
|
1984
Trinseo
TSE
$88.1M
| $4K | ﹤0.01% |
92
-9,596
| -99% | -$417K |
|
|
UBX
1985
DELISTED
Unity Biotechnology
UBX
| $4K | ﹤0.01% |
+348
| New | +$4K |
|
|
PFHD
1986
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $4K | ﹤0.01% |
169
| – | – |
|
|
EGLE
1987
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $4K | ﹤0.01% |
54
+42
| +350% | +$3.11K |
|
|
ACR
1988
ACRES Commercial Realty
ACR
$158M
| $3K | ﹤0.01% |
206
-149
| -42% | -$2.17K |
|
1989
Barclays
BCS
$69.1B
| $3K | ﹤0.01% |
383
-273
| -42% | -$2.14K |
|
1990
AB InBev
BUD
$118B
| $3K | ﹤0.01% |
+46
| New | +$3K |
|
1991
CalciMedica
CALC
$43M
| $3K | ﹤0.01% |
150
+92
| +159% | +$1.84K |
|
1992
CureVac
CVAC
$1.21B
| $3K | ﹤0.01% |
+169
| New | +$3K |
|
1993
DHI Group
DHX
$143M
| $3K | ﹤0.01% |
+451
| New | +$3K |
|
1994
DoubleVerify
DV
$2.45B
| $3K | ﹤0.01% |
+130
| New | +$3K |
|
1995
Epsilon Energy
EPSN
$126M
| $3K | ﹤0.01% |
518
| – | – |
|
1996
Hanmi Financial
HAFC
$751M
| $3K | ﹤0.01% |
+119
| New | +$3K |
|
1997
HSBC
HSBC
$227B
| $3K | ﹤0.01% |
89
-1
| -1% | -$34 |
|
1998
ING
ING
$71B
| $3K | ﹤0.01% |
253
+33
| +15% | +$391 |
|
1999
KALA BIO
KALA
$102M
| $3K | ﹤0.01% |
50
-1,333
| -96% | -$80K |
|
2000
Northrim BanCorp
NRIM
$502M
| $3K | ﹤0.01% |
+76
| New | +$3K |
|